143 related articles for article (PubMed ID: 38219914)
1. Promises and challenges of single-domain antibodies to control influenza.
Matthys A; Saelens X
Antiviral Res; 2024 Feb; 222():105807. PubMed ID: 38219914
[TBL] [Abstract][Full Text] [Related]
2. Broadly neutralizing antibodies recognizing different antigenic epitopes act synergistically against the influenza B virus.
Zhai L; Zhang L; Jiang Y; Li B; Yang M; Victorovich KV; Aleksandrovna KT; Li M; Wang Y; Huang D; Zeng Z; Ren Z; Cao H; Zhu L; Wu Q; Xiao W; Zhang B; Wan C; Wang F; Xia N; Zhao W; Chen Y; Shen C
J Med Virol; 2023 Jan; 95(1):e28106. PubMed ID: 36039848
[TBL] [Abstract][Full Text] [Related]
3. Broadly neutralizing antibodies to combat influenza virus infection.
Sun X; Ma H; Wang X; Bao Z; Tang S; Yi C; Sun B
Antiviral Res; 2024 Jan; 221():105785. PubMed ID: 38145757
[TBL] [Abstract][Full Text] [Related]
4. Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions.
Zhang A; Chaudhari H; Agung Y; D'Agostino MR; Ang JC; Tugg Y; Miller MS
Cell Rep Med; 2022 Aug; 3(8):100718. PubMed ID: 35977467
[TBL] [Abstract][Full Text] [Related]
5. Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies.
Piepenbrink M; Oladunni F; Nogales A; Khalil AM; Fitzgerald T; Basu M; Fucile C; Topham DJ; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
Microbiol Spectr; 2023 Aug; 11(4):e0472822. PubMed ID: 37318331
[TBL] [Abstract][Full Text] [Related]
6. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
7. Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.
Chen YQ; Lan LY; Huang M; Henry C; Wilson PC
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518651
[TBL] [Abstract][Full Text] [Related]
8. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.
Margine I; Krammer F; Hai R; Heaton NS; Tan GS; Andrews SA; Runstadler JA; Wilson PC; Albrecht RA; García-Sastre A; Palese P
J Virol; 2013 Oct; 87(19):10435-46. PubMed ID: 23903831
[TBL] [Abstract][Full Text] [Related]
9. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.
Bai Y; Jones JC; Wong SS; Zanin M
Viruses; 2021 Apr; 13(4):. PubMed ID: 33917376
[TBL] [Abstract][Full Text] [Related]
10. Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses.
Daulagala P; Mann BR; Leung K; Lau EHY; Yung L; Lei R; Nizami SIN; Wu JT; Chiu SS; Daniels RS; Wu NC; Wentworth D; Peiris M; Yen HL
mBio; 2023 Jun; 14(3):e0008423. PubMed ID: 37070986
[TBL] [Abstract][Full Text] [Related]
11. New antibody-based prevention and treatment options for influenza.
Sedeyn K; Saelens X
Antiviral Res; 2019 Oct; 170():104562. PubMed ID: 31323236
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
13. Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.
Cardoso FM; Ibañez LI; Van den Hoecke S; De Baets S; Smet A; Roose K; Schepens B; Descamps FJ; Fiers W; Muyldermans S; Depicker A; Saelens X
J Virol; 2014 Aug; 88(15):8278-96. PubMed ID: 24829341
[TBL] [Abstract][Full Text] [Related]
14. Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form.
Hoang PT; Luong QXT; Cho S; Lee Y; Na K; Ayun RQ; Vo TTB; Kim T; Lee S
PLoS One; 2022; 17(8):e0273934. PubMed ID: 36044435
[TBL] [Abstract][Full Text] [Related]
15. Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection.
Voronina DV; Shcheblyakov DV; Favorskaya IA; Esmagambetov IB; Dzharullaeva AS; Tukhvatulin AI; Zubkova OV; Popova O; Kan VY; Bandelyuk AS; Shmarov MM; Logunov DY; Naroditskiy BS; Gintsburg AL
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366583
[TBL] [Abstract][Full Text] [Related]
16. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.
Mittal N; Sengupta N; Malladi SK; Reddy P; Bhat M; Rajmani RS; Sedeyn K; Saelens X; Dutta S; Varadarajan R
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578291
[TBL] [Abstract][Full Text] [Related]
17. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
[TBL] [Abstract][Full Text] [Related]
18. Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action.
Abbadi N; Mousa JJ
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680239
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
[TBL] [Abstract][Full Text] [Related]
20. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM
Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
